Cancer Cell International · 2024 · 46 citations · 69 references
Life SciencesImmunologyOncologyCancer ImmunologyTumor ImmunologyVirologyAntiviral TherapyCancer ImmunotherapyOncogenic VirusesOncolytic Virus ImmunotherapyOncolytic Virus TherapyViral Immune EvasionCombination TherapyImmune Evasion By Oncogenic VirusesInflammation-driven Tumor ProgressionOncolytic Viral TherapyOncolytic Virus CombinationsTumor Suppression MechanismsTumor-associated InflammationVirus-mediated Tumor Lysis
As one of the significant challenges to human health, cancer has long been a focal point in medical treatment. With ongoing advancements in the field of medicine, numerous methodologies for cancer therapy have emerged, among which oncolytic virus therapy has gained considerable attention. However, oncolytic viruses still exhibit limitations. Combining them with various therapies can further enhance the efficacy of cancer treatment, offering renewed hope for patients. In recent research, scientists have recognized the promising prospect of amalgamating oncolytic virus therapy with diverse treatments, potentially surmounting the restrictions of singular approaches. The central concept of this combined therapy revolves around leveraging oncolytic virus to incite localized tumor inflammation, augmenting the immune response for immunotherapeutic efficacy. Through this approach, the patient's immune system can better recognize and eliminate cancer cells, simultaneously reducing tumor evasion mechanisms against the immune system. This review delves deeply into the latest research progress concerning the integration of oncolytic virus with diverse treatments and its role in various types of cancer therapy. We aim to analyze the mechanisms, advantages, potential challenges, and future research directions of this combination therapy. By extensively exploring this field, we aim to instill renewed hope in the fight against cancer.
69
Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle et al. · CA A Cancer Journal for Clinicians · 2023 · 16.7K citations · Full text
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
James R. Bischoff, David H. Kirn, Angelica Williams et al. · Science · 1996 · 1.8K citations
Medicine, Cancer Biology, Oncology +14
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas, Reinhard Dummer, Igor Puzanov et al. · Cell · 2017 · 1.5K citations · Full text
Medicine, Immunology, Oncology +12
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Robert L. Martuza, Amy Malick, James M. Markert et al. · Science · 1991 · 1K citations
Medicine, Cancer Biology, Oncology +14